Faeth Therapeutics Pulls In $47M Series A Posted by dumbcapital | Jul 5, 2022 | Raises and Exits, Uncategorized | 0 | SAN FRANCISCO, CA, Faeth Therapeutics, a cancer metabolism company, today announced the closing of a $47 million Series A round of private financing.